SCOTUS: No standing in challenge to mifepristone changes (FDA v. AHM)
The Supreme Court unanimously held the plaintiffs lacked Article III standing to challenge FDA’s 2016/2021 actions on mifepristone, leaving the agency’s changes in place. Justice Kavanaugh delivered the opinion, with the Court finding that the Alliance for Hippocratic Medicine failed to …
Supreme Court of the United States
Food and Drug Administration (FDA)
administrative-law
courts
standing
supreme-court
abortion-rights
Read more →